An Open Single Centre Study to Evaluate the Long-term Antibody Persistence and Immune Memory Between 16 and 20 Years After the Primary Study HAB-028 (208127/021) in Which Healthy Adults Were Vaccinated With Twinrix Adult Following a Three-dose Schedule.
Phase of Trial: Phase IV
Latest Information Update: 24 Nov 2015
At a glance
- Drugs Hepatitis A-hepatitis B vaccine (Primary) ; Hepatitis A vaccine inactivated; Hepatitis B vaccine recombinant
- Indications Hepatitis A; Hepatitis B
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 24 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Nov 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Jul 2014 to 1 Jun 2015.
- 06 Nov 2014 According to the ClinicalTrials.gov record, status changed from completed to active, no longer recruiting.